An open part of a China Drug Master File (DMF) contains non-confidential information accessible to applicants, such as manufacturing processes and quality controls. The restricted part includes confidential proprietary data, like detailed formulations and specific manufacturing methods, accessible only to regulatory authorities for evaluation, ensuring intellectual property protection.